<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>DA-SSL: self-supervised domain adaptor to leverage foundational models in turbt histopathology slides - Health AI Hub</title>
    <meta name="description" content="This paper introduces DA-SSL, a domain-adaptive self-supervised adaptor designed to overcome limitations of Pathology Foundational Models (PFMs) when applied to">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>DA-SSL: self-supervised domain adaptor to leverage foundational models in turbt histopathology slides</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2512.13600v1" target="_blank">2512.13600v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-12-15
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Haoyue Zhang, Meera Chappidi, Erolcan Sayar, Helen Richards, Zhijun Chen, Lucas Liu, Roxanne Wadia, Peter A Humphrey, Fady Ghali, Alberto Contreras-Sanz, Peter Black, Jonathan Wright, Stephanie Harmon, Michael Haffner
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2512.13600v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2512.13600v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces DA-SSL, a domain-adaptive self-supervised adaptor designed to overcome limitations of Pathology Foundational Models (PFMs) when applied to challenging histopathology slides like transurethral resection of bladder tumor (TURBT) specimens. DA-SSL efficiently realigns PFM features to the target domain without fine-tuning the foundational model. Piloting this framework for predicting neoadjuvant chemotherapy (NAC) treatment response in bladder cancer, the authors demonstrate its effectiveness with strong performance metrics, enhancing the applicability of AI in clinically complex scenarios.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is crucial for improving personalized medicine in bladder cancer by enabling AI models to accurately predict neoadjuvant chemotherapy response from real-world, often challenging, biopsy slides. This can help clinicians make informed treatment decisions, optimize patient outcomes, and potentially reduce unnecessary treatments for patients unlikely to benefit.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application is a deep learning system designed to adapt existing pathology foundational models (PFMs) to analyze challenging histopathology slides from TURBT procedures. The system aims to assist pathologists and clinicians in two key areas: improving the accuracy of diagnosing muscle-invasive bladder cancer and, more critically, predicting which patients with bladder cancer will benefit from neoadjuvant chemotherapy. This application directly supports clinical decision-making, potentially leading to more personalized and effective cancer treatment strategies.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Addresses domain shift limitations of Pathology Foundational Models (PFMs) in histopathology, particularly for specimens with artifacts like TURBT slides.</li>
                    
                    <li>Proposes DA-SSL (domain-adaptive self-supervised adaptor) to realign pre-trained PFM features to a target domain (TURBT) without requiring fine-tuning of the large foundational model.</li>
                    
                    <li>Leverages a lightweight, self-supervised approach for domain adaptation, making it efficient and practical for clinical deployment.</li>
                    
                    <li>Applied to the critical clinical task of predicting neoadjuvant chemotherapy (NAC) treatment response in muscle-invasive bladder cancer (MIBC) using TURBT histomorphological features.</li>
                    
                    <li>Achieved an AUC of 0.77+/-0.04 in five-fold cross-validation and, on an external test set, recorded an accuracy of 0.84, sensitivity of 0.71, and specificity of 0.91 via majority voting.</li>
                    
                    <li>Demonstrates that lightweight domain adaptation significantly enhances PFM-based Multiple Instance Learning (MIL) pipelines for challenging diagnostic and prognostic tasks.</li>
                    
                    <li>Code for the DA-SSL framework is made publicly available.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study proposes DA-SSL, a domain-adaptive self-supervised adaptor, to realign features from pre-trained Pathology Foundational Models (PFMs) to a target domain (TURBT histopathology slides). This adaptor integrates with existing Multiple Instance Learning (MIL) pipelines without fine-tuning the entire foundational model, making it lightweight. The framework was piloted for predicting NAC treatment response using a multi-center study design, evaluated via five-fold cross-validation (AUC) and an external test set using accuracy, sensitivity, and specificity calculated by majority voting.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>DA-SSL successfully adapted PFM features to the TURBT domain, yielding an AUC of 0.77+/-0.04 in cross-validation. On an external test set, the model achieved an accuracy of 0.84, sensitivity of 0.71, and specificity of 0.91 in predicting NAC treatment response for bladder cancer. These results demonstrate that a lightweight, self-supervised domain adaptation approach can effectively enhance PFM-based MIL pipelines for clinically challenging histopathology tasks.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The DA-SSL framework has the potential to significantly improve the stratification of muscle-invasive bladder cancer (MIBC) patients for neoadjuvant chemotherapy (NAC). By providing more accurate predictions of treatment response, it can facilitate personalized treatment decisions, ensuring that patients receive optimal therapy, minimizing overtreatment, and potentially improving survival rates and quality of life for MIBC patients.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract mentions piloting this framework, suggesting it is an initial study which typically implies a need for further validation on larger and more diverse patient cohorts to confirm generalizability and robustness across various clinical settings and demographics. The use of majority voting for the external test might also smooth over some individual sample variations.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly state future research directions. However, given the pilot nature of the study, implicit directions would include validation on larger, more diverse multicenter datasets, exploration of other cancer types or histopathological tasks facing similar domain shift challenges, and potential integration into prospective clinical trials to assess real-world utility.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Pathology</span>
                    
                    <span class="tag">Urology</span>
                    
                    <span class="tag">Oncology</span>
                    
                    <span class="tag">Medical Imaging</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">Histopathology</span>
                    
                    <span class="tag tag-keyword">Domain Adaptation</span>
                    
                    <span class="tag tag-keyword">Self-Supervised Learning</span>
                    
                    <span class="tag tag-keyword">Pathology Foundational Models</span>
                    
                    <span class="tag tag-keyword">Multiple Instance Learning</span>
                    
                    <span class="tag tag-keyword">Bladder Cancer</span>
                    
                    <span class="tag tag-keyword">TURBT</span>
                    
                    <span class="tag tag-keyword">Neoadjuvant Chemotherapy</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Recent deep learning frameworks in histopathology, particularly multiple instance learning (MIL) combined with pathology foundational models (PFMs), have shown strong performance. However, PFMs exhibit limitations on certain cancer or specimen types due to domain shifts - these cancer types were rarely used for pretraining or specimens contain tissue-based artifacts rarely seen within the pretraining population. Such is the case for transurethral resection of bladder tumor (TURBT), which are essential for diagnosing muscle-invasive bladder cancer (MIBC), but contain fragmented tissue chips and electrocautery artifacts and were not widely used in publicly available PFMs. To address this, we propose a simple yet effective domain-adaptive self-supervised adaptor (DA-SSL) that realigns pretrained PFM features to the TURBT domain without fine-tuning the foundational model itself. We pilot this framework for predicting treatment response in TURBT, where histomorphological features are currently underutilized and identifying patients who will benefit from neoadjuvant chemotherapy (NAC) is challenging. In our multi-center study, DA-SSL achieved an AUC of 0.77+/-0.04 in five-fold cross-validation and an external test accuracy of 0.84, sensitivity of 0.71, and specificity of 0.91 using majority voting. Our results demonstrate that lightweight domain adaptation with self-supervision can effectively enhance PFM-based MIL pipelines for clinically challenging histopathology tasks. Code is Available at https://github.com/zhanghaoyue/DA_SSL_TURBT.</p>
            </section>

            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>